RecruitingNot Applicable

Adverse Outcomes and Mortality in Liver Transplant

United States100 participantsStarted 2022-11-02

Plain-language summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All patients with end-stage liver disease undergoing evaluation for liver transplantation
✓. Patient clinically indicated for MRI during transplant candidacy evaluation
✓. Adult

What they're measuring

Muscle assessment score (MAsS)

Timeframe: 1 year

Adverse outcomes

Timeframe: 1 year

Adverse outcomes

Timeframe: 1 year

Adverse outcomes

Timeframe: 1 year

Adverse outcomes

Timeframe: 1 year

MAsS changes while waiting for liver transplant

Timeframe: 1 year

Trial details

NCT IDNCT05477277

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

Contact for this trial

Latasha Bunkley

480.342.5756 bunkley.latasha@mayo.edu

View on ClinicalTrials.gov More End Stage Liver DIsease trials